Electrolyte Disorders (Calcium, Magnesium, Phosphate) — Viva Defence

Opening statement (SASPOP, delivered aloud)

"Mrs Ward is a 72-year-old retired teacher with persistent asymptomatic mild hypercalcaemia and an inappropriately normal PTH — biochemistry that, once confounders are addressed, is most consistent with primary hyperparathyroidism. Her main problems are: first, confirming the diagnosis, which means dealing with the thiazide confounder and excluding familial hypocalciuric hypercalcaemia; second, her osteoporosis, where a femoral neck T-score of −2.6 technically meets a surgical criterion; and third, a genuine shared decision about parathyroidectomy versus surveillance in a well woman in her seventies. I would like to confirm the biochemistry cleanly, complete the stone-and-fracture screen, and then decide with her, not for her." [1]

Structured problem list

1. Persistent mild hypercalcaemia with inappropriately normal PTH — a PTH of 9.1 pmol/L with a calcium of 2.95 is not "normal": a properly suppressed gland should be undetectable at this calcium, so this is PTH-driven disease [3].
2. The thiazide confounder — hydrochlorothiazide reduces urinary calcium excretion and can both raise serum calcium modestly and unmask underlying parathyroid disease; the biochemistry must be re-proven off the drug [5].
3. FHH not yet excluded — the mimic that changes management from surgery to surveillance; needs a vitamin-D-replete urine calcium:creatinine clearance ratio and family history [2].
4. Osteoporosis — T-score −2.6 femoral neck; parathyroid disease preferentially erodes cortical bone, so this may be partly PTH-driven and partly post-menopausal — and it meets a workshop surgical criterion [1].
5. The decision itself — operate versus monitor in an asymptomatic, comorbidity-bearing older woman; her values and surgical fitness are part of the indication [1].

Integrated management plan

• Clean the biochemistry: substitute the antihypertensive (e.g. to a calcium-channel blocker) and repeat corrected calcium, phosphate, PTH and creatinine after 2–4 weeks off the thiazide; a calcium that persists elevated off the drug is parathyroid disease [5].
• Replete vitamin D then measure urine calcium: check 25-OH vitamin D, replete if low — deficiency both drives PTH up and collapses urinary calcium, which can fake an FHH ratio — then a 24-hour urine calcium with the calcium:creatinine clearance ratio. Below 0.01 with a positive family history supports FHH and ends the surgical conversation; above 0.02 supports primary hyperparathyroidism; the grey zone may need genetic testing [2] [6].
• Complete target-organ assessment: renal imaging for silent stones, creatinine clearance, vertebral fracture assessment, and a careful symptom review (polyuria, constipation, mood, cognition) — "asymptomatic" often becomes symptomatic on direct questioning [1].
• Apply the workshop criteria honestly: she meets a bone criterion (T-score at or below −2.5), so surgery is indicated by guideline — but indication is not obligation in a 72-year-old; the plan is a surgical opinion with explicit discussion of benefit (bone density improves after cure) against operative risk, with surveillance as the legitimate alternative [1].
• If monitored: annual calcium and creatinine, bone density every 1–2 years, renal imaging if symptoms change, and an explicit escape clause — progression of calcium, new stone, fracture or renal decline triggers re-referral [1].

Probing questions with model answers

"Her PTH is within the reference range. Why are you calling this hyperparathyroidism?" — "Because the reference range describes a gland at a normal calcium. At a calcium of 2.95 an intact negative feedback loop should suppress PTH to low or undetectable levels; a PTH of 9.1 is therefore inappropriately normal and indicates autonomous PTH-driven disease. Suppression, not the absolute number, is the read-out" [3].

"Why not just order a Sestamibi scan to confirm it?" — "Because the diagnosis is biochemical and the scan is anatomical. Sestamibi and 4D-CT localise an adenoma for the surgeon after the decision to operate; roughly a fifth of adenomas are scan-negative, so a negative scan cannot exclude the disease, and an incidental uptake does not prove it. Ordering it now would be the right test at the wrong step" [1].

"How does the thiazide change your interpretation?" — "Thiazides block the thiazide-sensitive cotransporter and reduce urinary calcium excretion, so they can raise serum calcium and also lower the urine calcium I need for the FHH ratio. I cannot interpret either the serum calcium or the clearance ratio until she has been off the drug for two to four weeks. If her calcium normalises completely and durably off the thiazide, the diagnosis weakens; if it persists, the thiazide has unmasked parathyroid disease rather than caused it" [5].

"What if her clearance ratio comes back below 0.01?" — "Then I would think hard about familial hypocalciuric hypercalcaemia — an inactivating calcium-sensing receptor mutation that raises the setpoint in parathyroid and kidney. The management consequence is total: FHH is not cured by parathyroidectomy, so I would check the family history, consider CASR genetic testing, and move her from a surgical pathway to surveillance — and I would first be sure her vitamin D was replete when the ratio was measured, because deficiency can fake it" [2] [4].

"She meets a surgical criterion. Would you tell her to have the operation?" — "I would tell her she has a guideline indication, and then frame the genuine choice: surgery is the only cure and her femoral neck bone density is likely to improve after cure; against that, she is well, her calcium is mild, and monitored surveillance is a legitimate evidence-based pathway with defined triggers for changing course. At 72 with reasonable fitness I would facilitate a surgical opinion so the decision is made with real operative risk numbers, and I would support either informed choice" [1].

"What would make you push harder toward surgery?" — "Age under fifty, calcium 0.25 mmol/L or more above the upper limit, any stone or hypercalciuria, creatinine clearance below 60, a fragility or vertebral fracture, or progression on monitoring — each is a workshop criterion, and her daughter's question 'will it affect my memory or mood?' deserves an honest 'the neurocognitive evidence is inconsistent, so I do not use it as an indication'" [1].

Communication points

• Explain the diagnosis in plain terms: a small gland has lost its thermostat; the blood calcium creeps up quietly and mostly affects bones and kidneys over years [1].
• Frame equipoise honestly — a guideline indication is a reason to discuss surgery, not an order to have it; document her priorities and the shared decision [1].
• If she chooses surveillance, give the specific escape symptoms (thirst, constipation, confusion, flank pain) and the monitoring schedule in writing, so "watch and wait" is a plan rather than a drift [1].